ReShape Lifesciences Net Income
| RSLSDelisted Stock | USD 15.68 3.60 29.80% |
As of the 20th of February, ReShape Lifesciences holds the Market Risk Adjusted Performance of (0.38), risk adjusted performance of 0.0259, and Semi Deviation of 10.74. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ReShape Lifesciences, as well as the relationship between them. Please check ReShape Lifesciences information ratio and downside variance to decide if ReShape Lifesciences is priced some-what accurately, providing market reflects its current price of 15.68 per share. Given that ReShape Lifesciences has jensen alpha of 0.3461, we recommend you to check out ReShape Lifesciences's recent market performance to make sure the company can sustain itself at a future point.
ReShape Lifesciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing ReShape Lifesciences' valuation are provided below:ReShape Lifesciences does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. ReShape |
Search Suggestions
| RS | Reliance Steel Aluminum | Company |
| RSBRX | Strategic Bond Fund | Mutual Fund |
| RSF | RiverNorth Specialty Finance | ETF |
| RSR | RSR | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, ReShape Lifesciences reported net income of (7.13 Million). This is 102.09% lower than that of the Health Care Equipment & Supplies sector and 102.99% lower than that of the Health Care industry. The net income for all United States stocks is 101.25% higher than that of the company.
ReShape Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ReShape Lifesciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ReShape Lifesciences could also be used in its relative valuation, which is a method of valuing ReShape Lifesciences by comparing valuation metrics of similar companies.ReShape Lifesciences is currently under evaluation in net income category among its peers.
ReShape Fundamentals
| Return On Equity | -1.2 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (0.48) % | |||
| Operating Margin | (1.65) % | |||
| Current Valuation | 35.03 M | |||
| Shares Outstanding | 2.39 M | |||
| Shares Owned By Insiders | 10.62 % | |||
| Shares Owned By Institutions | 1.30 % | |||
| Number Of Shares Shorted | 209.03 K | |||
| Price To Book | 30.42 X | |||
| Price To Sales | 1.30 X | |||
| Revenue | 8.01 M | |||
| Gross Profit | 4.57 M | |||
| EBITDA | (6.67 M) | |||
| Net Income | (7.13 M) | |||
| Cash And Equivalents | 11.49 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 967 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.12 X | |||
| Book Value Per Share | (8.66) X | |||
| Cash Flow From Operations | (4.43 M) | |||
| Short Ratio | 0.48 X | |||
| Earnings Per Share | (830.44) X | |||
| Price To Earnings To Growth | (12.12) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 17 | |||
| Beta | 1.9 | |||
| Market Capitalization | 9.35 M | |||
| Total Asset | 4.79 M | |||
| Retained Earnings | (642.7 M) | |||
| Working Capital | (397 K) | |||
| Net Asset | 4.79 M |
About ReShape Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ReShape Lifesciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ReShape Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ReShape Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in ReShape Stock
If you are still planning to invest in ReShape Lifesciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ReShape Lifesciences' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |